AKT1 and cancer: Akt is hyperactivated in cancer by multiple mechanisms, largely through the activation of its upstream regulator phosphoinositide 3-kinase (PI3K), which generates the phosphatidylinositol-3,4,5-trisphophate (PIP3) required for Akt activation (Mayer and Arteaga, 2016).